TrianglePUBLICATIONS · 27325857
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2016 Oct 20
- First author
- Hulin C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Hulin C
- type
- Author
- name
- Belch A
- type
- Author
- name
- Shustik C
- type
- Author
- name
- Petrucci MT
- type
- Author
- name
- Dührsen U
- type
- Author
- name
- Lu J
- type
- Author
- name
- Song K
- type
- Author
- name
- Rodon P
- type
- Author
- name
- Pégourié B
- type
- Author
- name
- Garderet L
- type
- Author
- name
- Hunter H
- type
- Author
- name
- Azais I
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hulin C
- type
- Author
- name
- Belch A
- type
- Author
- name
- Shustik C
- type
- Author
- name
- Petrucci MT
- type
- Author
- name
- Dührsen U
- type
- Author
- name
- Lu J
- type
- Author
- name
- Song K
- type
- Author
- name
- Rodon P
- type
- Author
- name
- Pégourié B
- type
- Author
- name
- Garderet L
- type
- Author
- name
- Hunter H
- type
- Author
- name
- Azais I
- type
- Author
- bibliography ids
- nci-bib-26bf61e11392ebe886db9523
- book metadata
- content sha256
- 464e9b0fc93912210061bcc8c7dfe4382555a03ca723635283b601c64eca71ce
- document type
- citation
- dois
- 10.1200/JCO.2016.66.7295
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27325857
- immutable id
- pubmed:27325857@464e9b0fc93912210061bcc8c7dfe4382555a03ca723635283b601c64eca71ce
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 30
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3609-3617
- volume
- 34
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 27325857
- provenance
- batch id
- fe5a46c92522c34737e8
- provider
- NCBI PubMed ESummary
- record sha256
- be767847dff9d20eeeca1ae37d40420ddb85e4e5cc6c117bd0f41ff0c6682ed8
- response sha256
- 2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
- retrieved at
- 2026-09-09T23:47:17.939307+00:00
- publication date
- display
- 2016 Oct 20
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.
Preserved source evidence · Not medical advice